"10.1371_journal.pone.0070409","plos one","2013-07-26T00:00:00Z","Kirsi Tamminen; Suvi Lappalainen; Leena Huhti; Timo Vesikari; Vesna Blazevic","Vaccine Research Center, University of Tampere School of Medicine, Tampere, Finland","Conceived and designed the experiments: VB KT SL TV. Performed the experiments: KT SL. Analyzed the data: KT SL VB. Contributed reagents/materials/analysis tools: SL KT VB LH. Wrote the manuscript: KT VB. Project and manuscript supervision: VB TV.","The authors have a patent on the use of norovirus virus-like particles and rotavirus rVP6 as a combination vaccine (patent no 122520). This study was in part supported by UMN Pharma Inc., Japan (www.umnpharma.com/en/) as compensation for licensing the patent (patent no 122520). This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","07","Kirsi Tamminen","KT",5,TRUE,4,2,3,2,TRUE,TRUE,FALSE,0,NA,FALSE
